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ABSTRACT
VEGETABLE PROTEIN INTAKE AND EARLY MENOPAUSE IN THE NURSES’
HEALTH STUDY II
MAY 2016
MAEGAN BOUTOT, B.A., THE COLLEGE OF NEW JERSEY
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Dr. Elizabeth Bertone-Johnson
Early menopause, the cessation of ovarian function prior to age 45, affects 5-10% of
Western women and is associated with an increased risk of adverse health outcomes,
including premature mortality and cardiovascular disease. Recent literature suggests that high
vegetable protein intake may prolong female reproductive function, but no study has
evaluated the association between this exposure and early menopause. Therefore, we
evaluated the relationship between cumulative vegetable protein intake as a percentage of
total calories and early menopause in the Nurses’ Health Study II cohort. Women included in
analyses were premenopausal at baseline (1991) and followed for up to 20 years. Cases
(n=2,077) were defined as women experiencing natural menopause before age 45; women
were excluded if early menopause was a result of hysterectomy, oophorectomy or radiation
treatment. Non-cases were women whose age at menopause was 45 or greater or who were
older than 45 and still premenopausal in 2011 (n=51,007). Intake of vegetable and animal
protein was assessed every four years via food frequency questionnaires. In Cox proportional
hazard models adjusting for age, smoking, diet, and behavioral factors, women in the highest
quintile of cumulatively averaged vegetable protein intake (median=6.5%) had a significant
18% lower likelihood of experiencing early menopause as compared to women in the lowest
iii

quintile (3.9%) (95% CI: 0.71-0.94; P-trend=0.004). In contrast, animal and total protein was
unrelated to risk. Results were similar in analyses limited to never smokers and never oral
contraceptive users. Our findings suggest vegetable protein intake may be inversely
associated with early menopause.
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CHAPTER 1
INTRODUCTION
Early menopause, or the cessation of ovarian function prior to the age 45, affects 510% of Western women and is associated with increased risk of adverse health outcomes,
including premature mortality and cardiovascular disease.1-3 Additionally, women who
develop early menopause may have reduced fertility as much as a decade prior to onset of
menopause.1,3 The causes of natural early menopause are not well understood, and the
majority of diagnoses are not attributable to genetic factors or autoimmune conditions.1,2
Recent literature has suggested that diet composition may be associated with rate of
ovarian aging, oocyte quality, and menopause timing.4-12 In particular, vegetable protein and
animal protein has been shown to have differential effects on ovarian function in animal
models.6 Appt et al. found that cynomolgus macaques randomly assigned to receive a soy
with isoflavins (i.e. vegetable protein) diet had more ovarian follicles than those randomized
to receive a casein and lactalbumin (i.e. animal protein) diet (in secondary follicles, N=39,
95%CI: 29-50 as compared to N=25, 95%CI: 17-35, p=0.05).6 To our knowledge, the
association between vegetable protein intake and early menopause has not been directly
evaluated.
We have investigated the relationship between vegetable protein intake and natural
early menopause among women enrolled in the Nurses’ Health Study (NHS) II. We
hypothesized that higher vegetable protein consumption would be inversely associated with
incidence of early menopause.
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CHAPTER 2
SUBJECT AND METHODS
The NHS II began in 1989 with the enrollment of 116,686 US female registered
nurses, aged 25-42, through the use of a mailed baseline health questionnaire.13 The
questionnaire was used to collect information on nurses’ current and lifelong health,
prescription medication use, and lifestyle factors.13 Participants have completed new
questionnaires every two years since, and the follow-up for each questionnaire cycle has been
at least 90%.13 The Institutional Review Board at Brigham and Women’s Hospital (Boston,
MA) approved of the NHS II study protocol.
A. Vegetable Protein Assessment
We assessed intake of total protein and protein from vegetable and animal sources in
1991 and every four years thereafter using the Harvard food frequency questionnaire (FFQ).
The FFQ was added to the surveys starting in 1991. The FFQ measures participants’ usual
intake of 131 foods, beverages and dietary supplements over the previous year. Participants
were asked to how often they consumed a single serving of an item using a 9 point scale,
ranging from “Never or less than once a month” to “6+ per day".15
Vegetable protein intake was calculated by multiplying the vegetable protein content
of a single serving of each food item by its frequency of consumption and then summing
across all items. Foods explaining the greatest amount of variation in vegetable protein intake
at baseline included pasta (7.85%), dark bread (6.33%), cold cereal (6.11%), and pizza
(6.10%). Soy intake explained 0.55% of the variation. Intakes of total protein, animal protein,
other macronutrients and micronutrients were derived similarly. We calculated vegetable and
animal protein intake as percentages of total calories by multiplying intake of each protein
2

type in grams by four (the number of kilocalories in one gram of protein), dividing by the
total number of calories consumed, and multiplying by 100. Intakes of micronutrients were
adjusted for total energy intake using the residual method.21
We excluded participants from analysis if they reported less than 600 kcal or more
than 3,500 kcal per day, were missing two or more sections of food categories, were missing
the entire section on sweets and other miscellaneous foods, were missing an entire page of
the FFQ, or did not provide information on more than 70 food items.14
The validity and reproducibility of the FFQ have been evaluated previously in a
similar cohort (the Nurses’ Health Study). In validation studies, the correlation coefficient for
total protein assessed using the FFQ in the NHS vs. from 4 weeks of daily food records was
0.47.16,17 Reproducibility within the same cohort was found to be high.17
B. Outcome Assessment
The present analysis was limited to NHS II participants who were premenopausal in
1991 and had a reported age at menopause or who were followed through 2011 and remained
premenopausal.14 Additionally, women younger than 45 who began using hormone
replacement therapy (HRT), had a hysterectomy, or had an oophorectomy were excluded.
Menopausal status and timing have been assessed every two years since 1989. First,
participants were asked if their menstrual periods had ceased, with response options of: “1)
No: Premenopausal; 2) Yes: No menstrual periods; 3) Yes: had menopause but now have
periods induced by hormones; and 4) Not sure (e.g., started hormones prior to cessation of
periods)”. Women who reported that their periods had ceased were asked to report the age at
which their periods ceased (open response) and for what reason their periods ceased: “1)
Surgery, 2) Radiation or chemotherapy, or 3) Natural”. Women were subsequently asked
3

about their use of replacement sex hormones. Because menopause is a transitional process
(perimenopause), it is not uncommon for women to be unsure of their menopausal status. 19,20
In our analyses, age of menopause was assigned by examining the pattern of responses given
on surveys from 1989 to 2011 to confirm correct menopausal status reports. Briefly, women
were assigned an age at menopause by using the age reported on the first questionnaire on
which they reported being postmenopausal, so long as they consistently did not report being
premenopausal on any subsequent questionnaire. For censoring purposes, we used age at
menopause in months assigned to the mid-year, which was derived by adding participants’
birthday in months plus six months plus derived age at menopause in years times 12. Women
who reported premenopausal on the 1991 survey, reported menopausal in the 1993 survey,
and whose derived age at menopause in months was before the midpoint were excluded from
analyses for not meeting baseline criteria of reporting premenopausal on the 1991 survey.
We classified women as having early menopause if their periods ceased naturally and
their age at menopause was less than 45. Non-cases included women whose age at
menopause was 45 or greater and women who were at least 45 years old and still
premenopausal at the end of follow-up in 2011. We retained women in our analysis who
reported surgical menopause, radiation/chemotherapy-induced menopause, and hormone
therapy use prior to menopause if these events first occurred after age 45. Our method of
assessing menopausal status in a prospective cohort has been validated in the both the NHS
cohort and a subgroup of women who provided medical record confirmation of menopause
age. Eighty-two percent of women experiencing natural menopause in the cohort repeatedly
recalled the same age at menopause within one year on repeated health questionnaires, while
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99% women whose age at menopause was confirmed via medical records accurately reported
their age at menopause within one year.20
C. Covariate Assessment
Additional dietary factors evaluated as confounders in our analysis were animal
protein as a percentage of total calories, total calories, saturated fat, vitamin D without
supplementation, B6 without supplementation, omega 3 intake, and calcium without
supplementation.1,4,6-8,12 As with protein intake, these factors were assessed every four years
starting in 1991 using the FFQ.
Lifestyle variables considered as possible confounders include physical activity in
METs per week, body mass index (BMI), smoking history in pack years, alcohol
consumption in grams/day, and ethnicity (white non-Hispanic or other).2,4,5,10 Physical
activity was assessed every four years using a frequency questionnaire consisting of eight
aerobic activities, including running and swimming. These responses were converted into
MET hours.22,23 BMI is derived using participants’ 1989 height and self-reported weight on
each two year survey.
Smoking pack-years was assessed from nurses’ self-reported smoking habits. Packyears were defined as the number of cigarettes smoked per day, and this value is carried
forward for non-respondents and for those who quit smoking. Alcohol consumption was
assessed biannually with three questions regarding the frequency of one serving of wine,
beer, and liquor. Ethnicity was self-reported in 1989.
Oral contraception, parity, breastfeeding, and age at menarche were considered
variables relevant to lifetime ovulation and were also tested in the model. Current oral
contraception use was assessed biannually from 1989 until 2011, and history and duration of
5

oral contraception was assessed in 1989. Parity, considered any pregnancy that lasted at least
6 months, was assessed biannually from 1989 until 2009. Months spent breastfeeding was
self-reported biannually from 1989 until 2003. Age at menarche was reported on the 1989
survey.
Additionally, to confirm that any potential relationship between vegetable protein
intake and early menopause was not related to total protein intake, cumulative total protein as
a percentage of total calories was run in all final models, excluding vegetable and animal
protein variables.
D. Statistical Analyses
We divided participants into quintiles of vegetable protein intake in 1991 based on
the distribution within the cohort. We then compared the distribution of covariates measured
at baseline with vegetable protein intake in age-adjusted general linear models.
We first evaluated the association between vegetable protein intake and early
menopause using age-adjusted Cox proportional hazards models to calculate hazard ratios
(HR) and 95% confidence intervals (CI). Cumulative average updating was used for dietary
variables, including vegetable protein intake, and BMI. To test for linear trend across
quintiles, we modeled the median value of each quintile as a continuous variable.
We included animal protein intake as a percentage of total calories and total calorie
intake in our multivariable models a priori due to their strong relationship with the exposure
variable and potential for confounding. All other potential covariates were evaluated for
confounding through the individual addition of each into an age-adjusted model of vegetable
protein intake as a percent of total calories, animal protein intake as a percent of total
calories, and total calorie intake. Covariates whose addition resulted in a 10% or greater
6

change in the HRs for vegetable protein were to be retained; however, no covariates caused a
10% or greater change in the HR of any quintiles of vegetable protein intake. Therefore, the
additional models were specified including risk factors from the literature. We decided upon
two additional models: 1) one adjusting for lifestyle variables only and 2) one adjusting for
lifestyle variables, variables related to cumulative number of lifetime ovulation, and dairy
protein intake as a percentage of total calories.
Animal protein, total calories, and dairy protein were broken into quintiles based on
the population distribution. BMI was categorized as <18.5, 18.5 to <25, 25 to <30, and ≥30.
Smoking in pack-years was categorized as never, < 20 years, and ≥20 years. Oral
contraceptive use was categorized into never, <2 years, and ≥2 years. Parity was categorized
into nulliparous, 1-2 children, and ≥3 children. Breastfeeding was categorized as never, <2
years, and ≥2 years. Age at menarche was categorized as 12<, 12 (referent), 13-15, and ≥16.
To address residual confounding by smoking status, we repeated our analyses in
never smokers, defined as participants who had zero pack-years of smoking at the end of
follow-up in 2011. Similarly, we also repeated our analyses in women who never used oral
contraceptives as of 2009 (oral contraceptive use was not reported in 2011).
Finally, we ascertained if timing of consumption was related to risk. To accomplish
this, we identified each participant’s protein intake at age 35 and at age 40 and then assessed
how intake at each time period was associated with risk in logistic regression models. In
order to preserve the prospective nature of these analyses, women whose age at menopause
was less than or equal to 40 were excluded. Additionally, only women with exposures for age
35 and age 40 were included in the models, such that the comparisons between groups would
be more interpretable. The same basic covariates used in the Cox models described
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previously; however, they were age specific rather than cumulative or updated. For example,
BMI associated with age 35 was used in the 35 model, similarly for age 40 models.
Statistical analyses were conducted with SAS v9.3 software (SAS Institute Inc, Cary,
NC).
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CHAPTER 3
RESULTS
After all exclusions, a total of 53,084 participants were included in our analyses and
2,077 women met criteria for early menopause.
Distributions of baseline covariates by quintile of vegetable protein consumption in
1991 are presented in Table 1. In general, women in the highest quintile of vegetable protein
intake were older, consumed fewer calories from animal protein, consumed fewer calories
overall, had a lower BMI, and were less likely to be parous. Despite being less parous,
however, these women were more likely to breastfeed longer, given they were parous.
Women in the fifth quintile were also more likely to be former smokers and less likely to be
current smokers; however, former and current smokers in the fifth quintile smoked less than
former or current smokers of the other quintiles. Women in the fifth quintile were also more
likely to have never used oral contraceptives and were less likely to have been using oral
contraceptives at baseline. In those who had used oral contraceptives (former or current),
women in the fifth quintile used oral contraceptives for fewer months.
More broadly, comparing characteristics by quintiles of vegetable protein, decreasing
linear trends from first to fifth quintile of vegetable protein were found for animal protein
consumption, BMI, percentage of current smokers, pack-years smoking, percentage of
current oral contraceptive users, and oral contraceptive use in months. For example, the
average, age-adjusted BMI for quintile five in 1991 was 23.6 and decreased continuously
towards quintile one. Similarly, increasing linear trends from first to fifth quintile were found
for age, percentage of former smokers, percentage of never oral contraceptive users, and
number of months breastfeeding in parous women (Table 1).
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In the age-adjusted Cox model (Model 1), women in the highest quintile of vegetable
protein intake (median = 6.5%) had a 21% lower likelihood of early menopause as compared
to women in the lowest quintile (median = 3.9%) (95% CI: 0.69-0.91; P-trend: 0.0006)
(Table 2). Addition of covariates only slightly attenuated results. When adjusting for all
covariates (Model 4), women in the highest quintile of vegetable protein intake had a
significant 18% lower likelihood of experiencing early menopause as compared to women in
the lowest quintile (95% CI: 0.71-0.94; P-trend=0.004). In contrast, neither animal protein
intake (P-trend Model 4 = 0.825) nor total protein intake (P-trend Model 4 = 0.791)was
associated with risk of early menopause (Table 2).
Results limited to never smokers (N=34,602, 1,238 cases) and never oral
contraceptive users (N=6,387, 228 events) were similar to results including the whole cohort
(data not shown).
Results from logistic regression models comparing vegetable protein intake suggested
that there may be differential effects by age (N=13,911 with 533 incidence early menopause
cases) (Table 3). No significant associations were found between vegetable protein intake at
35 and incidence of early menopause; however, the odds ratios reported looked similar to
those found for the age 40 analyses. In the age 40 analyses, women in the highest quintile of
vegetable protein intake (median=6.8%) had a 33% lower odds of early menopause as
compared to women in the lowest quintile (median=3.8%) when adjusting for age (95% CI:
0.51-0.871; P-trend=0.005). These results were attenuated but remained significant when
adjusting for animal protein, total calories, smoking in pack-years, and BMI. Upon the
addition of age specific Model 4 covariates, the results were no longer significant.
Specifically, women in the highest quintile of vegetable protein consumption are at a non-

10

significant 24.9% lower likelihood of early menopause as compared to women in the first
quintile (95% CI: 0.56-1.004, P-trend=0.11).
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CHAPTER 4
DISCUSSION
In this prospective study, we found that high vegetable protein intake was
significantly associated with lower likelihood of early menopause. Conversely, animal
protein intake and total protein intake were not associated with early menopause.
Our results do not directly correspond to previous research done in the field, as our
outcome was concerned primarily with the outcome of early menopause, in contrast to age at
menopause. Disregarding that difference, there is only one study, to our knowledge, that has
examined vegetable protein intake and age at menopause. Nagata et al. (2000) reported a
non-linear association between vegetable protein intake, in grams, and age at menopause in
1,130 Japanese women. After adjusting for age BMI, smoking status, and age at which
menses became regular, women in the second tertile of vegetable protein intake had a 51%
higher risk of menopause than women in the first tertile. However, when adjusting for the
same covariates, women in the third tertile of vegetable protein intake had no significant
change in risk of menopause as compared to the first tertile (HR=0.99, 95%CI: 0.73-1.34).10
However, because these women only reported a single baseline dietary intake and were, on
average, older than our cohort (range: 35-54 years of age, mean: 42.7, SD: 4.3)10, the
association presented does not necessarily reflect a long-term cumulative effect of vegetable
protein intake, nor does it correspond well to assessing the outcome of early menopause
Additionally, women in the Japanese cohort may be eating different sources of
vegetable protein; women in the Japanese cohort reported median soy intake of 44 grams to
114 grams (approximately 1 to 4 ounces) per day, whereas, at baseline, the majority (89%) of
the NHS II cohort included in our analyses reported “never or less than once per month”
consumption of 3 to 4 ounces of soy and less than 1% reported one or more servings per day.
12

Rather, as mentioned previously, vegetable protein consumption in the NHS II cohort
appears to be wheat based. This difference may be important as Nagata et al. (1998) found
that higher consumers of soy had a lower age at menopause in a cross-sectional study24;
however, they did not find such an association in their more recent study, nor did other
studies of European and Asian women.4,5,10
Our results for total protein and animal protein intake are more in line with the
literature, as neither of these factors have been found to be associated with age at
menopause.4,5,10
Given that controlling for confounding by animal protein intake had no effect on the
effect estimates in the vegetable protein models and that total protein showed no association
with early menopause, we believe that the risks shown are related to the specific effect of
vegetable protein on outcome. The biological mechanism through vegetable protein acts on
early menopause unknown. After finding that cynomolgus macaques randomly assigned to
receive a soy-with-isoflavins diet had more ovarian follicles than those randomized to receive
a casein-and-lactalbumin diet, Appt et al. (2010) suggested that soy isoflavones or their
metabolites,

possibly functioning as exogenous estrogens, may slow ovarian aging by

decreasing inflammation or oxidative stress.6 It is unclear if this mechanism functions in this
scenario however, as vegetable protein in the NHS II cohort is derived mostly from wheat
products, making the percentage of daily calories from soy products much smaller than those
consumed by the macaques. Relatedly, the results from Appt. et al contradict the
epidemiological studies by Nagata et al.10, 23
Results from our target age analyses suggest that vegetable protein consumption at
age 40 may decrease the occurrence of early menopause, whereas results from age 35 suggest
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a weaker, if any, association. It is important to note that these results only apply to women
who undergo menopause between 40 and 45, as other women with early menopause were be
excluded to keep the data prospective. These results may be detecting a narrow window of
exposure, in that exposure at age 35 is not strong enough to affect an outcome five to ten
years in the future, whereas exposure at 40 has a much stronger impact for the upcoming one
to five years. If an association between age 35 consumption and menopause between 40 and
45 does exist, it is possible that we were underpowered to detect an effect of age 35
exposure, as we lost many participants due to missing data. Nevertheless, these results
suggest that women may be able to prolong menopause through vegetable protein
consumption at age 40.
A main limitation of our study is that our exposure and outcome were self-reported.
Cumulative vegetable protein intake was calculated using multiple self-reported FFQs.
Although this technique is both common and validated, it is possible that women incorrectly
reported their intake due to a misunderstanding of what constitutes a single serving of a food,
causing an under or overestimation depending on the food, or due to a desire of having a
better diet; however, adjusting for total calories and percent of total energy would reduce
misclassification. Additionally, women would have to misreport for vegetable protein
sources while still accurately reporting for animal protein and other dietary variables, which
seems unlikely. Similarly, age at menopause was self-reported; however, reporting has been
shown to be highly accurate within this population.20 If some misclassification did occur, we
would expect the error would be non-differential, and thus the HR would be, on average,
biased towards the null.
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In regards to generalizability, we would expect that our results would be
generalizable to populations with similar vegetable protein consumption and main sources of
vegetable protein. Considering that, it is possible that populations that, on average, eat much
higher amounts of vegetable protein may experience a plateau effect, such that higher
consumption of vegetable protein would not necessarily lead to decreased incidence of early
menopause. Similarly, it is possible that in populations where the main sources of vegetable
protein are different than those in NHS II cohort, the relationship may not hold. This latter
finding would possibly shed light upon the mechanism by which our vegetable protein acts
upon the reproductive system.
In conclusion, long term vegetable protein intake is associated with a reduced
likelihood in the incidence of early menopause. Given the potential public health impact this
may have and how unstudied early menopause is in the literature, more studies are warranted
to discern which foods, if any, have the greatest impact, possible unaccounted confounders,
and the biological mechanism that drives this relationship.
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Tables

Table 1. Distribution of 1991 Age Standardized Covariates According to % Calories from Vegetable Protein in 1991; NHS II,
1991-2011.
Q1
(n=9973)
Characteristic 1
Age (Years)2,3
% of Calories from Animal Protein
Total Caloric Intake
Body Mass Index (BMI)
Smoking Status4
%Never5
%Former5
%Current5
Pack-Years (PY) Smoking6
Oral Contraceptive Use 4
%Never5
%Former5
%Current5
Oral Contraceptive Use (Months)6
Parity (Pregnancies≥6 Months)
Percent Parious4
Breastfeeding (Months)7
Age at Menarche (Years)

% Calories from Vegetable Protein
Q2
Q3
Q4
(n=10470)
(n=10765)
(n=10930)

Q5
(n=10946)

Median: 3.7%
36.3 (4.6)
15.9 (0.0)
1796 (5.4)
25.0 (0.1)

Median: 4.4%
36.5 (4.5)
15.1 (0.03)
1818 (5.3)
24.6 (0.1)

Median: 4.9%
36.8 (4.4)
14.5 (0.0)
1810 (5.2)
24.5 (0.1)

Median: 5.4%
37.0 (4.3)
13.9 (0.0)
1788 (5.2)
24.2 (0.1)

Median: 6.3%
37.2 (4.3)*
12.1 (0.0)*
1736 (5.2)*
23.6 (0.1)*

63.5
22.2
14.3
13.5 (0.14)

66.6
23.4
10.0
12.1 (0.14)

66.7
24.8
8.5
11.6 (0.14)

66.7
25.6
7.7
11.2 (0.14)

65.34*
28.1*
6.6*
11.0 (0.13)*

16.3
72.5
11.5
50.9 (0.5)
1.6 (0.01)
75.0
10.5 (0.16)
12.5 (0.01)

16.9
72.6
10.6
48.3 (0.5)
1.7 (0.01)
77.8
12.9 (0.15)
12.5 (0.01)

16.7
72.8
10.5
47.1 (0.5)
1.7 (0.01)
78.5
13.4 (0.15)
12.4 (0.01)

17
73.6
9.4
45.7 (0.5)
1.7 (0.01)
77.0
14.2 (0.15)
12.4 (0.01)

18.4*
72.9*
8.7*
42.9 (0.5)*
1.5 (0.01)*
71.6*
15.6 (0.16)*
12.4 (0.01)*

1

Values are means and SEs or percentages standardized to the age distribution of the study population in 1991.

2

Values are not age-adjusted.

3

Standard deviation reported instead of standard error.

4

Percentage

5

P represents difference across all categories of use (never, former, current)

6

Former and current users only

7

Parious women only
*P <0.01
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Table 2. Unadjusted and Adjusted Hazard Ratios and 95% Confidence Intervals for Protein Intake and Early Menopause; NHS II 1991-2011.
Early Menopause
Model 1
Model 2
Model 3
Model 4
Median Cases
HR
95% CI
HR
95% CI
HR
95% CI
HR
95% CI
% Calories from Vegetable Protein
1st Quintile
3.9%
456
1.0
Referent
1.0
Referent
1.0
Referent
1.0
Referent
2nd Quintile
4.6%
410
0.84 0.73 0.96
0.84 0.73 0.96
0.87 0.76 0.99
0.88 0.76 1.00
3rd Quintile
5.1%
429
0.86 0.75 0.98
0.86 0.75 0.98
0.90 0.78 1.03
0.91 0.79 1.04
4th Quintile
5.6%
386
0.77 0.67 0.88
0.77 0.67 0.88
0.81 0.70 0.93
0.81 0.71 0.94
5th Quintile
6.5%
396
0.79 0.69 0.91
0.77 0.67 0.89
0.81 0.70 0.94
0.82 0.71 0.94
p-trend
0.0006
0.0002
0.003
0.004
% Calories from Animal Protein*
1st Quintile
2nd Quintile
3rd Quintile
4th Quintile
5th Quintile
p-trend

10.0%
12.2%
13.7%
15.4%
17.9%

427
420
410
416
404

1.0
0.96
0.95
1.00
1.04

Referent
0.84 1.10
0.83 1.09
0.87 1.14
0.90 1.19
0.485

1.0
0.95
0.92
0.95
0.94

Referent
0.83 1.09
0.80 1.06
0.83 1.10
0.81 1.08
0.450

1.0
0.96
0.94
0.97
0.96

Referent
0.83 1.10
0.81 1.08
0.84 1.11
0.83 1.12
0.703

1.0
0.98
0.97
1.01
1.01

Referent
0.86 1.13
0.85 1.12
0.88 1.17
0.86 1.17
0.825

% Calories from Total Protein+
1st Quintile
2nd Quintile
3rd Quintile
4th Quintile
5th Quintile
p-trend

15.4%
17.5%
18.9%
20.4%
22.8%

423
436
405
412
401

1.0
1.01
0.96
0.99
1.03

Referent
0.88 1.16
0.83 1.10
0.86 1.14
0.90 1.18
0.756

1.0
1.01
0.95
0.98
1.00

Referent
0.88 1.16
0.83 1.09
0.85 1.12
0.87 1.15
0.867

1.0
1.03
0.97
1.00
1.03

Referent
0.90 1.18
0.85 1.12
0.87 1.15
0.89 1.18
0.845

1.0
1.06
1.01
1.05
1.06

Referent
0.93 1.22
0.88 1.16
0.91 1.21
0.92 1.23
0.791

M odel 1 Age-adjusted
M odel 2 Adjusted for animal protein (quintiles) and total calories (quintiles)
M odel 3 Adjusted for M odel 2 covariates, BM I (categorical), and pack-years smoking (categorical)
Adjusted for M odel 3 covariates, percent calories from dairy protein (quintiles), age at menarche (categorical), total months breastfeeding (categorical), OC use (categorical),
M odel 4 parity (categorical)
* Adjusted for vegetable protein in place of animal protein in M odels 1-4
+ Not adjusted for vegetable protein, animal protein, or dairy protein in M odels 1-4
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Table 3. Adjusted Odds Ratios and 95% Confidence Intervals for Vegetable Protein Intake at Age 40 and Age 35 and Early Menopause; NHS II 1991-2011.
Early Menopause
Model 1
Model 2
Model 3
Model 4
Median
Cases
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
% Calories from Vegetable
Protein at Age 40
Referent
Referent
Referent
Referent
1st Quintile
3.84%
111
1.00
1.00
1.00
1.00
2nd Quintile
4.56%
91
0.77 0.58 1.02
0.80 0.60 1.06
0.82 0.62 1.10
0.85 0.63 1.13
3rd Quintile
5.10%
101
0.80 0.61 1.05
0.84 0.63 1.11
0.88 0.67 1.17
0.91 0.69 1.21
4th Quintile
5.69%
116
0.81 0.62 1.06
0.86 0.65 1.14
0.92 0.70 1.21
0.94 0.71 1.25
5th Quintile
6.77%
114
0.67 0.51 0.87
0.69 0.52 0.92
0.74 0.55 0.98
0.75 0.56 1.00
p-trend
0.01
0.03
0.09
0.11
% Calories from Vegetable
Protein at Age 35
Referent
Referent
Referent
Referent
1st Quintile
3.74%
111
1.00
1.00
1.00
1.00
2nd Quintile
4.43%
93
0.81 0.61 1.08
0.82 0.62 1.09
0.84 0.64 1.12
0.86 0.64 1.14
3rd Quintile
4.94%
114
0.96 0.74 1.25
0.97 0.74 1.26
0.99 0.76 1.30
1.01 0.77 1.32
4th Quintile
5.46%
108
0.93 0.71 1.22
0.91 0.69 1.20
0.95 0.72 1.25
0.95 0.72 1.26
5th Quintile
6.44%
107
0.89 0.67 1.16
0.80 0.60 1.07
0.83 0.62 1.11
0.82 0.61 1.09
p-trend
0.64
0.24
0.34
0.28
M odel 1 Age-adjusted
M odel 2 Adjusted for animal protein (quintiles) and total calories (quintiles)
M odel 3 Adjusted for M odel 2 covariates, BM I (categorical), and pack-years smoking (categorical)
M odel 4 Adjusted for M odel 3 covariates, dairy protein (quintiles), age at menarche (categorical), total months breastfeeding (categorical), OC use (categorical), and parity (categorical)
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